Market Analysis and Insights: Global Autoimmune Disorders Treatment Market
The global Autoimmune Disorders Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on immune system.
Report Includes
This report presents an overview of global market for Autoimmune Disorders Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Autoimmune Disorders Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Autoimmune Disorders Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autoimmune Disorders Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Autoimmune Disorders Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Autoimmune Disorders Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Johnson & Johnson, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Sanofi and Merck, etc.
By Company
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck
Pfizer
Segment by Type
Bridge Therapy
Recombinant Technology
Fecal Bacteriotherapy
Hematopoietic Stem-cell Transplantation
Phototherapy
Helminthic Therapy
Activation-induced Assays
Segment by Application
Systemic Autoimmune Diseases
Localized Autoimmune Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Autoimmune Disorders Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disorders Treatment companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Disorders Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bridge Therapy
1.2.3 Recombinant Technology
1.2.4 Fecal Bacteriotherapy
1.2.5 Hematopoietic Stem-cell Transplantation
1.2.6 Phototherapy
1.2.7 Helminthic Therapy
1.2.8 Activation-induced Assays
1.3 Market by Application
1.3.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Systemic Autoimmune Diseases
1.3.3 Localized Autoimmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disorders Treatment Market Perspective (2018-2029)
2.2 Global Autoimmune Disorders Treatment Growth Trends by Region
2.2.1 Autoimmune Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Autoimmune Disorders Treatment Historic Market Size by Region (2018-2023)
2.2.3 Autoimmune Disorders Treatment Forecasted Market Size by Region (2024-2029)
2.3 Autoimmune Disorders Treatment Market Dynamics
2.3.1 Autoimmune Disorders Treatment Industry Trends
2.3.2 Autoimmune Disorders Treatment Market Drivers
2.3.3 Autoimmune Disorders Treatment Market Challenges
2.3.4 Autoimmune Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Autoimmune Disorders Treatment by Players
3.1.1 Global Autoimmune Disorders Treatment Revenue by Players (2018-2023)
3.1.2 Global Autoimmune Disorders Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Autoimmune Disorders Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Autoimmune Disorders Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disorders Treatment Revenue in 2022
3.5 Global Key Players of Autoimmune Disorders Treatment Head office and Area Served
3.6 Global Key Players of Autoimmune Disorders Treatment, Product and Application
3.7 Global Key Players of Autoimmune Disorders Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disorders Treatment Breakdown Data by Type
4.1 Global Autoimmune Disorders Treatment Historic Market Size by Type (2018-2023)
4.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2024-2029)
5 Autoimmune Disorders Treatment Breakdown Data by Application
5.1 Global Autoimmune Disorders Treatment Historic Market Size by Application (2018-2023)
5.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Autoimmune Disorders Treatment Market Size (2018-2029)
6.2 North America Autoimmune Disorders Treatment Market Size by Type
6.2.1 North America Autoimmune Disorders Treatment Market Size by Type (2018-2023)
6.2.2 North America Autoimmune Disorders Treatment Market Size by Type (2024-2029)
6.2.3 North America Autoimmune Disorders Treatment Market Share by Type (2018-2029)
6.3 North America Autoimmune Disorders Treatment Market Size by Application
6.3.1 North America Autoimmune Disorders Treatment Market Size by Application (2018-2023)
6.3.2 North America Autoimmune Disorders Treatment Market Size by Application (2024-2029)
6.3.3 North America Autoimmune Disorders Treatment Market Share by Application (2018-2029)
6.4 North America Autoimmune Disorders Treatment Market Size by Country
6.4.1 North America Autoimmune Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Autoimmune Disorders Treatment Market Size by Country (2018-2023)
6.4.3 North America Autoimmune Disorders Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Autoimmune Disorders Treatment Market Size (2018-2029)
7.2 Europe Autoimmune Disorders Treatment Market Size by Type
7.2.1 Europe Autoimmune Disorders Treatment Market Size by Type (2018-2023)
7.2.2 Europe Autoimmune Disorders Treatment Market Size by Type (2024-2029)
7.2.3 Europe Autoimmune Disorders Treatment Market Share by Type (2018-2029)
7.3 Europe Autoimmune Disorders Treatment Market Size by Application
7.3.1 Europe Autoimmune Disorders Treatment Market Size by Application (2018-2023)
7.3.2 Europe Autoimmune Disorders Treatment Market Size by Application (2024-2029)
7.3.3 Europe Autoimmune Disorders Treatment Market Share by Application (2018-2029)
7.4 Europe Autoimmune Disorders Treatment Market Size by Country
7.4.1 Europe Autoimmune Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Autoimmune Disorders Treatment Market Size by Country (2018-2023)
7.4.3 Europe Autoimmune Disorders Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Autoimmune Disorders Treatment Market Size (2018-2029)
8.2 China Autoimmune Disorders Treatment Market Size by Type
8.2.1 China Autoimmune Disorders Treatment Market Size by Type (2018-2023)
8.2.2 China Autoimmune Disorders Treatment Market Size by Type (2024-2029)
8.2.3 China Autoimmune Disorders Treatment Market Share by Type (2018-2029)
8.3 China Autoimmune Disorders Treatment Market Size by Application
8.3.1 China Autoimmune Disorders Treatment Market Size by Application (2018-2023)
8.3.2 China Autoimmune Disorders Treatment Market Size by Application (2024-2029)
8.3.3 China Autoimmune Disorders Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Autoimmune Disorders Treatment Market Size (2018-2029)
9.2 Asia Autoimmune Disorders Treatment Market Size by Type
9.2.1 Asia Autoimmune Disorders Treatment Market Size by Type (2018-2023)
9.2.2 Asia Autoimmune Disorders Treatment Market Size by Type (2024-2029)
9.2.3 Asia Autoimmune Disorders Treatment Market Share by Type (2018-2029)
9.3 Asia Autoimmune Disorders Treatment Market Size by Application
9.3.1 Asia Autoimmune Disorders Treatment Market Size by Application (2018-2023)
9.3.2 Asia Autoimmune Disorders Treatment Market Size by Application (2024-2029)
9.3.3 Asia Autoimmune Disorders Treatment Market Share by Application (2018-2029)
9.4 Asia Autoimmune Disorders Treatment Market Size by Region
9.4.1 Asia Autoimmune Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Autoimmune Disorders Treatment Market Size by Region (2018-2023)
9.4.3 Asia Autoimmune Disorders Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Autoimmune Disorders Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disorders Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Autoimmune Disorders Treatment Introduction
11.2.4 Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.2.5 Roche Diagnostics Recent Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Autoimmune Disorders Treatment Introduction
11.3.4 Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.3.5 Siemens Healthcare Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Autoimmune Disorders Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Introduction
11.5.4 Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Disorders Treatment Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.7.5 AstraZeneca Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Autoimmune Disorders Treatment Introduction
11.8.4 Sanofi Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.8.5 Sanofi Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Autoimmune Disorders Treatment Introduction
11.9.4 Merck Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.9.5 Merck Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Autoimmune Disorders Treatment Introduction
11.10.4 Pfizer Revenue in Autoimmune Disorders Treatment Business (2018-2023)
11.10.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck
Pfizer
听
听
*If Applicable.
